71 related articles for article (PubMed ID: 4456497)
1. Lack of effect of amantadine on d-amphetamine-induced release of dopamine from cat brain in vivo.
Gudelsky GA; McCall RB; Chiueh CC; Moore KE
Res Commun Chem Pathol Pharmacol; 1974 Dec; 9(4):653-60. PubMed ID: 4456497
[No Abstract] [Full Text] [Related]
2. Effects of alpha-methyltyrosine on d-amphetamine-induced release of endogenously synthesized and exogenously administered catecholamines from the cat brain in vivo.
Chiueh CC; Moore KE
J Pharmacol Exp Ther; 1974 Jul; 190(1):100-8. PubMed ID: 4847307
[No Abstract] [Full Text] [Related]
3. Involvement of nigro-striatal neurons in the in vivo release of dopamine by amphetamine, amantadine and tyramine.
Von Voigtlander PF; Moore KE
J Pharmacol Exp Ther; 1973 Mar; 184(3):542-52. PubMed ID: 4687219
[No Abstract] [Full Text] [Related]
4. Dopamine and norepinephrine uptake by rat brain synaptosomes: relative inhibitory potencies of 1- and d-amphetamine and amantadine.
Thornburg JE; Moore KE
Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):81-9. PubMed ID: 4686111
[No Abstract] [Full Text] [Related]
5. Relative potencies of d- and l-amphetamine on the release of dopamine from cat brain in vivo.
Chiueh CC; Moore KE
Res Commun Chem Pathol Pharmacol; 1974 Jan; 7(1):189-99. PubMed ID: 4811449
[No Abstract] [Full Text] [Related]
6. Blockade by reserpine of methylphenidate-induced release of brain dopamine.
Chiueh CC; Moore KE
J Pharmacol Exp Ther; 1975 May; 193(2):559-63. PubMed ID: 1142104
[TBL] [Abstract][Full Text] [Related]
7. Dopamine: release from the brain in vivo by amantadine.
Von Voigtlander PF; Moore KE
Science; 1971 Oct; 174(4007):408-10. PubMed ID: 5111993
[TBL] [Abstract][Full Text] [Related]
8. Effects of amphetamine on the contents of norepinephrine and its metabolites in the effluent of perfused cerebral ventricles of the cat.
Carr LA; Moore KE
Biochem Pharmacol; 1970 Jul; 19(7):2361-74. PubMed ID: 5520379
[No Abstract] [Full Text] [Related]
9. In vivo release of H 3 -dopamine from the brain during the administration of haloperidol.
Von Voigtlander PF; Moore KE
Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):223-32. PubMed ID: 4686106
[No Abstract] [Full Text] [Related]
10. The effect of dihydroxyphenylalanine, pheniprazine and dextroamphetamine on the in vivo release of dopamine from the caudate nucleus.
McKenzie GM; Szerb JC
J Pharmacol Exp Ther; 1968 Aug; 162(2):302-8. PubMed ID: 4385909
[No Abstract] [Full Text] [Related]
11. Release of endogenously synthesized catechols from the caudate nucleus by stimulation of the nigro-striatal pathway and by the administration of d-amphetamine.
Chiueh CC; Moore KE
Brain Res; 1973 Feb; 50(1):221-5. PubMed ID: 4690549
[No Abstract] [Full Text] [Related]
12. Compartmentation of dopamine in rat striatum.
Doteuchi M; Wang C; Costa E
Mol Pharmacol; 1974 Mar; 10(2):225-34. PubMed ID: 4152816
[No Abstract] [Full Text] [Related]
13. Comparative effects of dl-p-methoxyamphetamine and d-amphetamine on catecholamine release and reuptake in vitro.
Tseng LF; Hitzemann RJ; Loh HH
J Pharmacol Exp Ther; 1974 Jun; 189(3):708-16. PubMed ID: 4843169
[No Abstract] [Full Text] [Related]
14. Proceedings: Responses of cortical pyramidal tract cells to amantadine and amphetamine after depletion of central catecholamines.
Stone TW
Br J Pharmacol; 1975 Jun; 54(2):244P-245P. PubMed ID: 1148533
[No Abstract] [Full Text] [Related]
15. In vivo release of endogenously synthesized catecholamines from the cat brain evoked by electrical stimulation and by d-amphetamine.
Chiueh CC; Moore KE
J Neurochem; 1974 Jul; 23(1):159-68. PubMed ID: 4852387
[No Abstract] [Full Text] [Related]
16. Dietary cadmium exposure attenuates D-amphetamine-evoked [3H]dopamine release from striatal slices and methamphetamine-induced hyperactivity.
Miller DK; Dopheide MM; Smith SM; Casteel SW
Pharmacol Biochem Behav; 2005 Apr; 80(4):557-66. PubMed ID: 15820525
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the locomotor stimulant properties of amantadine and l- and d-amphetamine in mice.
Thornburg JE; Moore KE
Neuropharmacology; 1972 Sep; 11(5):675-82. PubMed ID: 4151250
[No Abstract] [Full Text] [Related]
18. Norepinephrine: release from brain by d-amphetamine in vivo.
Carr LA; Moore KE
Science; 1969 Apr; 164(3877):322-3. PubMed ID: 5776642
[TBL] [Abstract][Full Text] [Related]
19. The role if dopamine and norepinephrine uptake inhibition in mediating the central effects of d-amphetamine in vivo.
Feigenbaum JJ; Yanai J; Blass RB
Res Commun Chem Pathol Pharmacol; 1982 Feb; 35(2):333-5. PubMed ID: 7071417
[TBL] [Abstract][Full Text] [Related]
20. Interactions between a novel cholinergic ion channel agonist, SIB-1765F and L-DOPA in the reserpine model of Parkinson's disease in rats.
Menzaghi F; Whelan KT; Risbrough VB; Rao TS; Lloyd GK
J Pharmacol Exp Ther; 1997 Jan; 280(1):393-401. PubMed ID: 8996220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
